Cambridge Healthtech Institute第一屆

Drug Discovery for Rare Diseases

( 罕見疾病療法的開發 )

聚焦於基因體標的、蛋白質體標的、藥物形式的論壇

2018年3月28日 | Boston Marriott Cambridge | 馬薩諸塞州劍橋

罕見疾病是影響非常少數人的疾病,近年來其重要度及關注程度逐漸提升。美國國家衛生研究院指出,現在世界上有將近7,000種罕見疾病的存在,超過2,500萬美國人罹患這些疾病,而約有80%的罕見疾病被認為與基因有關。本論壇以罕見疾病療法的開發為主題,開發各種罕見疾病療法的主要研究人員、臨床醫師、企業幹部、專家將聚集於此,針對新創藥標的、正在研究的胜肽與低聚核苷酸藥物形式等主題進行議論。本論壇為時一天,各種專業領域的人齊聚一堂,探討轉譯研究的課題,針對本領域潛在商業機會交換意見,不但是獨一無二的活動,協助研究罕見疾病的研究人員與專業技術人員,和贊助商企業幹部交換意見、建立合作關係也是重要的目的之一。

Who should attend: Scientists, Lab Managers, Clinicians, Team Leads, Directors and Executives from Pharma, Biotech, Academia, Government, Contract Research Labs and Technology Providers involved in Drug Discovery & Development, Functional Screening, Target Identification and Validation, Biomarker Discovery, Translational and Clinical Research, Bioinformatics, Diagnostics, Alliance Management, and other areas important to Rare Diseases.

Topics will include, but are not limited to:

  • Update on peptide and oligonucleotide drugs for treating rare diseases
  • Evaluating new models and approaches to identify novel drug targets and biologic modalities
  • Using CRISPR, stem cells, and other innovative tools for understanding and treating rare diseases
  • Finding computational and bioinformatics tools for identifying disease pathways and drug targets
  • Exploiting proteomics, genomics, and metabolomics tools for drug and target discovery
  • Exploring gene therapy, cell therapy, and gene editing

The deadline for submission is September 15, 2017.

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

* 活動內容有可能不事先告知作更動及調整。